newsfilter
← Latest News
Business Wire·

Lantern Pharma Inc. Announces up to $8 Million Registered Direct Offering

$4 million upfront with up to an additional $4 million of potential aggregate gross proceeds upon the exercise in full of the warrants Lantern Pharma Inc. (NASDAQ:LTRN) ("Lantern", the "Company" or